Concepedia

Shekhar Dhokai

SD

Statistics

Publications

3

Citations

134

H-Index

3

Active since

2016

Affiliations

Biogen (United States)(Current)

Shekhar Dhokai is an author at Biogen (United States) specializing in parkinson disease, desaturase enzymes, and nanoparticle drug delivery.

Publications per year

2016–2022

3

Publications

3

Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models

Can Sarısözen, Shekhar Dhokai, Edcar G. Tsikudo et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2016 · 105 citations

, , +17

SCD Inhibition Protects from α-Synuclein-Induced Neurotoxicity But Is Toxic to Early Neuron Cultures

Justin W. Nicholatos, Joost Groot, Shekhar Dhokai et al. · eNeuro · 2021 · 19 citations · Full text

, , +17

Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> disease

Mélanie Jambeau, Kevin D. Meyer, Marián Hruška-Plocháň et al. · Proceedings of the National Academy of Sciences · 2022 · 10 citations · Full text

, , +17

1–3 of 3